Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 01, 2014 (Vol. 34, No. 7)

Getting More from ADME-Tox Assays

  • Increasing R&D efficiency is the pharmaceutical industry’s largest challenge as the industry grapples with the major issue of drug attrition. Killing compounds that should be killed earlier would provide significant cost reductions and improve drug development economics. Recent advances in ADME-Tox assays may be the key. According ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.